Obios

Advancing Diagnostic Precision in Metabolic Medicine

We are building the missing diagnostic layer in obesity and nutrition medicine. Today, treatment decisions are still guided mainly by body weight, questionnaires, and trial and error. We measure ingestive behaviour directly, with medical-grade sensors, signal processing, and digital biomarkers that capture how people actually consume food and drinks. This creates a new class of actionable data for diagnosis, treatment selection, and therapy monitoring. Our platform can help identify who responds to which intervention, track therapeutic success earlier, and support more precise care in metabolic medicine. In short, we turn behaviour into measurable physiology for precision health.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

No news

Deal

02.03.2026

Submission of BRIDGE PoC grant

Deal

12.01.2024

Expansion of collaborations with research institutes in Middle East Asia.

Milestone

18.12.2023

Presented our project to the VC Company Wingman

Milestone

15.12.2023

Garnered interest from major pharmaceutical firms.

Deal

31.10.2023

Secured 50 ready-to-buy customers.

Show more...

No Jobs

No videos and documents

No Awards

Obios

Advancing Diagnostic Precision in Metabolic Medicine

Headquarter:
Zurich

Technology:

  • Medtech

Sectors:

  • Cloud
  • Digital Health
  • Diagnostics
  • Hardware
  • Machine Learning / AI
  • Medical devices
  • Sensors
  • Medtech
  • Research and development
  • SaaS
  • Services for companies
  • Software
  • Patient monitoring
  • Screening